Polymer electrolyte membrane (PEM) fuel cells, which convert the chemical energy stored
in hydrogen fuel directly and efficiently to electrical energy with water as the only byproduct, …

We performed an extensive immunogenomic analysis of more than 10,000 tumors comprising
33 diverse cancer types by utilizing data compiled by TCGA. Across cancer types, we …

Determining the genetic basis of cancer requires comprehensive analyses of large collections
of histopathologically well-classified primary tumours. Here we report the results of a …

Background The full complement of DNA mutations that are responsible for the pathogenesis
of acute myeloid leukemia (AML) is not yet known. Methods We used massively parallel …

Most patients with acute myeloid leukaemia (AML) die from progressive disease after relapse,
which is associated with clonal evolution at the cytogenetic level 1 , 2 . To determine the …

Structural variants are implicated in numerous diseases and make up the majority of varying
nucleotides among human genomes. Here we describe an integrated set of eight structural …

The INK4a gene encodes two distinct growth inhibitors—the cyclin-dependent kinase inhibitor
p16 Ink4a , which is a component of the Rb pathway, and the tumor suppressor p19 Arf , …

Most mutations in cancer genomes are thought to be acquired after the initiating event,
which may cause genomic instability and drive clonal evolution. However, for acute myeloid …

Detection and characterization of genomic structural variation are important for understanding
the landscape of genetic variation in human populations and in complex diseases such as …

Acute myeloid leukaemia is a highly malignant haematopoietic tumour that affects about
13,000 adults in the United States each year. The treatment of this disease has changed little in …